A common drug slashes your risk of hospitalisation after Covid by as much as a third.
An antidepressant costing just 29p was given to half in a new study, with the other participants getting a placebo.
The study took place in Brazil, in South America, and its research has now been published in the Lancet.
…Fluvoxamine is branded as Faverin in the UK, and was found to reduce the hospital risk by 32 per cent in Covid sufferers.
Edward Mills, a researcher at McMaster University, Canada, which co-led the study, said: “Fluvoxamine is, so far, the only treatment that if administered early, can prevent Covid-19 from becoming a life-threatening illness.